Supernus Pharmaceuticals (SUPN) Leases (2019 - 2025)
Historic Leases for Supernus Pharmaceuticals (SUPN) over the last 7 years, with Q3 2025 value amounting to $28.8 million.
- Supernus Pharmaceuticals' Leases changed N/A to $28.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.8 million, marking a year-over-year change of. This contributed to the annual value of $24.5 million for FY2024, which is 1557.91% down from last year.
- Latest data reveals that Supernus Pharmaceuticals reported Leases of $28.8 million as of Q3 2025.
- In the past 5 years, Supernus Pharmaceuticals' Leases ranged from a high of $35.4 million in Q4 2021 and a low of $21.9 million during Q2 2025
- Moreover, its 5-year median value for Leases was $29.3 million (2022), whereas its average is $28.6 million.
- In the last 5 years, Supernus Pharmaceuticals' Leases soared by 5547.11% in 2021 and then plummeted by 1826.95% in 2022.
- Supernus Pharmaceuticals' Leases (Quarter) stood at $35.4 million in 2021, then dropped by 18.27% to $28.9 million in 2022, then rose by 0.31% to $29.0 million in 2023, then fell by 15.58% to $24.5 million in 2024, then increased by 17.5% to $28.8 million in 2025.
- Its Leases stands at $28.8 million for Q3 2025, versus $21.9 million for Q2 2025 and $24.5 million for Q4 2024.